Simon A. Surguladze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simon A. Surguladze has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Joaquim Radua
IDIBAPS, CIBERSAM, Institute of Neuroscience University of Barcelona Barcelona Spain
3 shared publications - Wissam El-Hage
INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, Université de Tours
3 shared publications - Anthony S. David
University College London
2 shared publications - Bénédicte Gohier
Department of Psychiatry and Addictology Angers University Hospital Angers France
2 shared publications M.L. Phillips
2 shared publications- Allison Maree McKendrick
Department of Optometry & Vision Science School of Health and Clinical Sciences University of Western Australia Perth Western Australia Australia
1 shared publication
Latest Publications
- 1 September 2015
- Published by Elsevier in Psychiatry Research
- Vol. 229 (1-2) , 340-346
Empathy costs: Negative emotional bias in high empathisers
- 1 September 2015
- Published by Elsevier in Psychiatry Research
- Vol. 229 (1-2) , 340-346
Empathy costs: Negative emotional bias in high empathisers
- Open Access
- 17 January 2012
- Published by Springer Nature in Translational Psychiatry
- Vol. 2 (1) , e70
Interaction of catechol O-methyltransferase and serotonin transporter genes modulates effective connectivity in a facial emotion-processing circuitry
Imaging genetic studies showed exaggerated blood oxygenation level-dependent response in limbic structures in carriers of low activity alleles of serotonin transporter-linked promoter region (5-HTTLPR) as well as catechol O-methyltransferase (COMT) genes. This was suggested to underlie the vulnerability to mood disorders. To better understand the mechanisms of vulnerability, it is important to investigate the genetic modulation of frontal-limbic connectivity that underlies emotional regulation and control. In this study, we have examined the interaction of 5-HTTLPR and COMT genetic markers on effective connectivity within neural circuitry for emotional facial expressions. A total of 91 healthy Caucasian adults underwent functional magnetic resonance imaging experiments with a task presenting dynamic emotional facial expressions of fear, sadness, happiness and anger. The effective connectivity within the facial processing circuitry was assessed with Granger causality method. We have demonstrated that in fear processing condition, an interaction between 5-HTTLPR (S) and COMT (met) low activity alleles was associated with reduced reciprocal connectivity within the circuitry including bilateral fusiform/inferior occipital regions, right superior temporal gyrus/superior temporal sulcus, bilateral inferior/middle prefrontal cortex and right amygdala. We suggest that the epistatic effect of reduced effective connectivity may underlie an inefficient emotion regulation that places these individuals at greater risk for depressive disorders.
- 17 January 2012
- Published by Springer Nature in Translational Psychiatry
- Vol. 2 (1) , e70
Open AccessInteraction of catechol O-methyltransferase and serotonin transporter genes modulates effective connectivity in a facial emotion-processing circuitry
Imaging genetic studies showed exaggerated blood oxygenation level-dependent response in limbic structures in carriers of low activity alleles of serotonin transporter-linked promoter region (5-HTTLPR) as well as catechol O-methyltransferase (COMT) genes. This was suggested to underlie the vulnerability to mood disorders. To better understand the mechanisms of vulnerability, it is important to investigate the genetic modulation of frontal-limbic connectivity that underlies emotional regulation and control. In this study, we have examined the interaction of 5-HTTLPR and COMT genetic markers on effective connectivity within neural circuitry for emotional facial expressions. A total of 91 healthy Caucasian adults underwent functional magnetic resonance imaging experiments with a task presenting dynamic emotional facial expressions of fear, sadness, happiness and anger. The effective connectivity within the facial processing circuitry was assessed with Granger causality method. We have demonstrated that in fear processing condition, an interaction between 5-HTTLPR (S) and COMT (met) low activity alleles was associated with reduced reciprocal connectivity within the circuitry including bilateral fusiform/inferior occipital regions, right superior temporal gyrus/superior temporal sulcus, bilateral inferior/middle prefrontal cortex and right amygdala. We suggest that the epistatic effect of reduced effective connectivity may underlie an inefficient emotion regulation that places these individuals at greater risk for depressive disorders.
- 31 December 2010
- Published by Elsevier in Schizophrenia Research
- Vol. 124 (1-3) , 134-141
Backward and forward visual masking in schizophrenia and its relation to global motion and global form perception
- 31 December 2010
- Published by Elsevier in Schizophrenia Research
- Vol. 124 (1-3) , 134-141
Backward and forward visual masking in schizophrenia and its relation to global motion and global form perception
- Open Access
- 1 December 2010
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 38 (3) , 599-607
The McCollough Effect and Facial Emotion Discrimination in Patients With Schizophrenia and Their Unaffected Relatives
Abnormalities in visual processing have been found consistently in schizophrenia patients, including deficits in early visual processing, perceptual organization, and facial emotion recognition. There is however no consensus as to whether these abnormalities represent heritable illness traits and what their contribution is to psychopathology. Fifty patients with schizophrenia, 61 of their first-degree healthy relatives, and 50 psychiatrically healthy volunteers were tested with regard to facial affect (FA) discrimination and susceptibility to develop the color-contingent illusion [the McCollough Effect (ME)]. Both patients and relatives demonstrated significantly lower accuracy in FA discrimination compared with controls. There was also a significant effect of familiality: Participants from the same families had more similar accuracy scores than those who belonged to different families. Experiments with the ME showed that schizophrenia patients required longer time to develop the illusion than relatives and controls, which indicated poor visual adaptation in schizophrenia. Relatives were marginally slower than controls. There was no significant association between the measures of FA discrimination accuracy and ME in any of the participant groups. Facial emotion discrimination was associated with the degree of interpersonal problems, as measured by the Schizotypal Personality Questionnaire in relatives and healthy volunteers, whereas the ME was associated with the perceptual-cognitive symptoms of schizotypy and positive symptoms of schizophrenia. Our results support the heritability of FA discrimination deficits as a trait and indicate visual adaptation abnormalities in schizophrenia, which are symptom related.
- 1 December 2010
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 38 (3) , 599-607
Open AccessThe McCollough Effect and Facial Emotion Discrimination in Patients With Schizophrenia and Their Unaffected Relatives
Abnormalities in visual processing have been found consistently in schizophrenia patients, including deficits in early visual processing, perceptual organization, and facial emotion recognition. There is however no consensus as to whether these abnormalities represent heritable illness traits and what their contribution is to psychopathology. Fifty patients with schizophrenia, 61 of their first-degree healthy relatives, and 50 psychiatrically healthy volunteers were tested with regard to facial affect (FA) discrimination and susceptibility to develop the color-contingent illusion [the McCollough Effect (ME)]. Both patients and relatives demonstrated significantly lower accuracy in FA discrimination compared with controls. There was also a significant effect of familiality: Participants from the same families had more similar accuracy scores than those who belonged to different families. Experiments with the ME showed that schizophrenia patients required longer time to develop the illusion than relatives and controls, which indicated poor visual adaptation in schizophrenia. Relatives were marginally slower than controls. There was no significant association between the measures of FA discrimination accuracy and ME in any of the participant groups. Facial emotion discrimination was associated with the degree of interpersonal problems, as measured by the Schizotypal Personality Questionnaire in relatives and healthy volunteers, whereas the ME was associated with the perceptual-cognitive symptoms of schizotypy and positive symptoms of schizophrenia. Our results support the heritability of FA discrimination deficits as a trait and indicate visual adaptation abnormalities in schizophrenia, which are symptom related.
- 1 October 2010
- Published by Elsevier in NeuroImage
- Vol. 53 (1) , 58-64
Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives
- 1 October 2010
- Published by Elsevier in NeuroImage
- Vol. 53 (1) , 58-64
Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives
- 1 October 2010
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 44 (14) , 894-902
Depression is associated with increased sensitivity to signals of disgust: A functional magnetic resonance imaging study
- 1 October 2010
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 44 (14) , 894-902
Depression is associated with increased sensitivity to signals of disgust: A functional magnetic resonance imaging study
- Open Access
- 1 July 2010
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 6 (1) , 455-464
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
Bipolar disorder is a life-long psychiatric illness characterized by a high frequency of relapses and substantial societal costs. Almost half of the patients are prescribed second generation antipsychotics for treatment of manic states, or as the maintenance therapy. Risperidone long acting injection (RLAI) as a monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder was approved by Food and Drug Administration (FDA) in United States in May 2009. In this review we will consider the aspects of pharmacology, pharmacokinetics, metabolism, safety and tolerability, and clinical trials focusing on the efficacy of RLAI in bipolar disorder. The patients’ perspective and attitudes to long-acting injections will also be discussed.
- 1 July 2010
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 6 (1) , 455-464
Open AccessEmerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
Bipolar disorder is a life-long psychiatric illness characterized by a high frequency of relapses and substantial societal costs. Almost half of the patients are prescribed second generation antipsychotics for treatment of manic states, or as the maintenance therapy. Risperidone long acting injection (RLAI) as a monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder was approved by Food and Drug Administration (FDA) in United States in May 2009. In this review we will consider the aspects of pharmacology, pharmacokinetics, metabolism, safety and tolerability, and clinical trials focusing on the efficacy of RLAI in bipolar disorder. The patients’ perspective and attitudes to long-acting injections will also be discussed.
- 1 April 2010
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 25 (6) , 722-733
Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication
We employed two event-related functional magnetic resonance imaging tasks using the pictures of mild and intense facial emotions of fear or happiness. The sample comprised 16 chronic schizophrenia patients treated with risperidone long-acting injections (RLAI), 16 patients treated with conventional antipsychotic depots (CONV) and 16 healthy controls (HC). The HC and RLAI groups demonstrated greater activation in the left amygdala in response to intensively fearful faces, and in right cerebellum to intensively happy faces compared with CONV patients. The CONV group demonstrated under-activation in the right temporal pole in response to intensively happy faces (compared with HC) and over-activation in ventro-medial prefrontal cortex (VMPFC) in response to both intensively happy and fearful expressions, compared with HC and RLAI groups. Our results suggest that networks implicated in the allocation of attentional resources (VMPFC) and emotion processing (amygdala, cerebellum) are differentially affected in patients on CONV versus RLAI.
- 1 April 2010
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 25 (6) , 722-733
Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication
We employed two event-related functional magnetic resonance imaging tasks using the pictures of mild and intense facial emotions of fear or happiness. The sample comprised 16 chronic schizophrenia patients treated with risperidone long-acting injections (RLAI), 16 patients treated with conventional antipsychotic depots (CONV) and 16 healthy controls (HC). The HC and RLAI groups demonstrated greater activation in the left amygdala in response to intensively fearful faces, and in right cerebellum to intensively happy faces compared with CONV patients. The CONV group demonstrated under-activation in the right temporal pole in response to intensively happy faces (compared with HC) and over-activation in ventro-medial prefrontal cortex (VMPFC) in response to both intensively happy and fearful expressions, compared with HC and RLAI groups. Our results suggest that networks implicated in the allocation of attentional resources (VMPFC) and emotion processing (amygdala, cerebellum) are differentially affected in patients on CONV versus RLAI.